Christoffer Gebhardt

40PUBLICATIONS
131CO-AUTHORS
Solid tumoursPredictive and prognostic markersNanotoxicology, health and safetyTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 15, 2026
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ Recipients.

|Jul 01, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

|Mar 15, 2026
Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.

Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler

|Mar 05, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan, Miso Kim, Ignacio Mendez

|Feb 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal, Dirk Debus, Lisa Zimmer

|Feb 04, 2026
Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence.

Julian Kött, Nina Matthes, Alexander T Bauer

Pageof 7

Frequent Collaborators

16 joint publications

Julian Kött

12 joint publications

Glenn Geidel

7 joint publications

Jessica C Hassel

7 joint publications

Klaus Pantel